微创盆腔器官脱垂手术当日与次日出院30天再入院比较
这项回顾性队列研究纳入2008至2018年一家大型管理式医疗组织内13445例微创盆腔重建手术患者,比较当日出院与次日出院的30天再入院风险。结果显示两组30天再入院率无差异(1.5% vs 2.0%,OR 0.79,95%CI 0.60-1.03,P=.07),30天急诊就诊率亦无统计学差异;作者认为当日出院可能安全。
要点
- 微创盆腔重建手术后当日出院与次日出院的30天再入院率无差异。
- 合并子宫切除的亚组中,当日与次日出院的30天再入院率同样无差异。
- 校正患者及围术期特征后,再入院风险仍无统计学显著差异。
核心结论
- 在大型管理式医疗组织中,微创盆腔重建手术当日出院与次日出院的30天再入院率和急诊就诊率无差异。
- 考虑患者因素后,微创盆腔重建手术当日出院可能安全,并可能在价值导向医疗中发挥作用。
研究设计与样本
- 共13445例患者,其中5506例当日出院、7939例次日出院。
- 主要结局为30天再入院,次要结局为30天急诊就诊。
- 统计采用卡方检验、Kruskal-Wallis检验及多因素logistic回归。
主要发现
- 全队列30天再入院率当日出院1.5% vs 次日出院2.0%(OR 0.79;95%CI 0.60-1.03;P=.07)。
- 合并子宫切除者(n=6171)30天再入院率1.9% vs 2.1%(OR 0.90;95%CI 0.60-1.33;P=.59)。
- 经阴道子宫切除者(n=3482)30天再入院率2.8% vs 2.1%(OR 1.33;95%CI 0.79-2.26;P=.28)。
- 未行子宫切除者30天再入院率1.3% vs 1.7%(OR 0.77;95%CI 0.53-1.13;P=.18)。
- 校正后合并子宫切除者aOR 0.91(95%CI 0.61-1.36;P=.63),未合并者aOR 0.86(95%CI 0.58-1.27;P=.45)。
关键数值与推荐
- 全队列30天再入院:当日出院1.5% vs 次日出院2.0%,OR 0.79(95%CI 0.60-1.03),P=.07。
- 合并子宫切除亚组30天再入院:1.9% vs 2.1%,OR 0.90(95%CI 0.60-1.33),P=.59。
- 经阴道子宫切除亚组30天再入院:2.8% vs 2.1%,OR 1.33(95%CI 0.79-2.26),P=.28。
- 未行子宫切除亚组30天再入院:1.3% vs 1.7%,OR 0.77(95%CI 0.53-1.13),P=.18。
- 30天急诊就诊:全队列、合并子宫切除亚组及校正后比较均无统计学显著差异。
临床怎么用
- 微创盆腔器官脱垂重建手术后可考虑当日出院,未观察到30天再入院或急诊就诊增加。
- 合并子宫切除或经阴道子宫切除的患者,当日出院与次日出院的再入院风险无统计学差异。
- 当日出院可作为价值导向医疗下的围术期管理选项之一。
局限性
- 为回顾性队列研究,可能存在选择偏倚与混杂。
- 数据来自单一大型管理式医疗组织,外推需谨慎。
- 仅评估30天再入院与急诊就诊,未涉及其他结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effect of same-day discharge on 30-day readmission risk after minimally invasive pelvic reconstructive surgery. METHODS: This retrospective cohort study included all minimally invasive pelvic reconstructive procedures with and without concomitant hysterectomy performed within a large managed care organization of 4.5 million members from 2008 to 2018. We queried the system-wide medical record for Current Procedural Terminology and International Classification of Diseases, Ninth and Tenth Revision codes for all included procedures and patient perioperative data. Our primary outcome was 30-day hospital readmission, and our secondary outcome was 30-day emergency department (ED) visits. Perioperative data and 30-day outcomes were compared using χ for categorical variables and Kruskal-Wallis for continuous variables. We performed a multivariate logistic regression adjusting for perioperative variables and their potential effect. RESULTS: Of the 13,445 patients undergoing pelvic reconstructive surgery, 5,506 were discharged the same day and 7,939 were discharged the next day. There was no difference in 30-day readmission comparing those discharged the same day with those discharged the next day (odds ratio [OR] 0.79; 95% CI 0.60-1.03; 1.5% vs 2.0%, P=.07). Concomitant hysterectomy was performed in 6,171 individuals: There was no difference (OR 0.90; 95% CI 0.60-1.33; 1.9% vs 2.1%, P=.59) in 30-day readmission rates when comparing those discharged on the same day with those discharged the next day. We also found no difference in 30-day readmissions rates when comparing same-day with next-day discharge (OR 1.33, 95% CI 0.79-2.26; 2.8% vs 2.1%, P=.28) in (n=3,482) individuals undergoing vaginal hysterectomy. For those who did not undergo hysterectomy at the time of their prolapse surgery, there was no difference (OR 0.77; 95% CI 0.53-1.13; 1.3% vs 1.7%, P=.18) in 30-day readmission when comparing those discharged the same day with those discharged the next day. After adjustment for patient and perioperative characteristics, there was no statistically significant difference in the readmission risk for individuals with same-day discharge compared with next-day discharge among those with (adjusted odds ratio [aOR] 0.91; 95% CI 0.61-1.36; P=.63) and without (aOR 0.86; 95% CI 0.58-1.27; P=.45) a concomitant hysterectomy. For the secondary outcome of 30-day ED visits, we found no statistically significant differences when comparing same-day with next-day discharge for the entire cohort, those with concomitant hysterectomy, or when controlling for patient and perioperative characteristics. CONCLUSION: In women undergoing minimally invasive pelvic reconstructive surgery within a large managed care organization, there is no difference in 30-day readmission or ED visit rates between those discharged the same day and those discharged the next day. When considering patient factors, same-day discharge after minimally invasive pelvic reconstructive surgery may be safe and play an important role in value-based care.
引用
- Berger AA, Tan-Kim J, Menefee SA, et al. Comparison of 30-Day Readmission After Same-Day Compared With Next-Day Discharge in Minimally Invasive Pelvic Organ Prolapse Surgery. Obstet Gynecol. 2020. PMID: 32459424. doi:10.1097/AOG.0000000000003871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。